Pharma stocks sag; Dr Reddy’s Labs, Sun Pharma, Lupin top drags
NEW DELHI: A majority of pharma stocks were trading in the lower terrain in Monday’s trading session, keeping the sectoral pack down. The Nifty Pharma index was trading 0.47 per…
Health ministry likely to ban over 300 combo drugs
NEW DELHI: The health ministry may soon ban over 300 fixed-dose combination (FDC) medicines, accepting recommendations of a sub-committee of India’s apex drug advisory body. The move, which is expected…
Allergan sues Pfizer over costs of opioid litigation
Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively…
Chinese biotech Ascletis rallies in HK debut, in test of new market rules
HONG KONG: Shares in Chinese biotech company Ascletis Pharma Inc rose as much as 6.4 percent on their debut in Hong Kong on Wednesday, in the first such listing in…
Safe Point expresses cautious optimism on national plan for safe injections
New Delhi: Hope floated for the advocates of National Swachha Injection Abhiyan with the launch of National Viral Hepatitis Control Program by the Government of India. But they have expressed…
To check counterfeit medications, the working group may vet a plan
To weed out the fake drugs from the market, India’ central drug regulator “The Central Drugs Standard Control Organization (CDSCO) “is making a working group to basically assess its proposition…
Sun Pharma recalls over 2,500 bottles of diabetes drug from US
The US arm of Sun Pharmaceutical Industries is recalling over 2,500 bottles of Metformin hydrochloride extended release tablets from Arizona on account of presence of foreign substance in one lot.…
‘New found’ faith in Generics giving Branded medicines run for money
New Delhi: Happiness is writ large on Indian healthcare, thanks to generic medicines catching up fast. Patients are in for an unprecedented savings on medicines. To put it in StayHappi…
P&G, J&J cut sanitary napkin prices by 2-3%
Mumbai: Leading sanitary napkin makers Procter & Gamble (P&G) and Johnson & Johnson (J&J) on Friday passed on to consumers the benefits of the GST exemption on feminine hygiene products.…
Abbott India quits MNC lobby, ties up with IPA
NEW DELHI: In what could be a major setback for the multinational pharmaceutical lobby in India, American drug maker Abbott has quit Organisation of Pharmaceutical Producers of India (OPPI) primarily…
